JAMA Dermatol 2017 Jul 01
Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors.
Related Questions
New answer by Medical Oncologist at Mayo Clinic, Rochester (February 27, 2023)
Pan-FGFR inhibitors as a class can cause significant dermatologic toxic effects (including alopecia, dry skin, nail changes, and stomatitis) anywhere in the range of 20% to 45...